Watchlist Price Alert

Marinus Pharmaceuticals I... (MRNS)

NASDAQ: MRNS · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: Feb 10, 2025, 3:59 PM

Marinus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-141.41M	-19.82M	-98.78M	-67.47M	-54.12M	-36.73M	-18.9M	-28.64M
Depreciation & Amortization	551K	418K	355K	334K	278K	127K	126K	23K
Stock-Based Compensation	15.56M	14.89M	13.87M	7.64M	5.67M	4.79M	2.88M	3.08M
Other Working Capital	-2.55M	-4.27M	20.86M	-3.92M	-1.48M	6.17M	-779K	1.4M
Other Non-Cash Items	5.12M	-102.29M	1.06M	626K	94K	-79K	4K	7K
Deferred Income Tax	n/a	n/a	-687K	3K	34K	n/a	-28K	n/a
Change in Working Capital	2.17M	-6.09M	28.7M	-2.04M	-590K	4.05M	-2.9M	767K
Operating Cash Flow	-118M	-112.89M	-55.48M	-60.91M	-48.63M	-27.84M	-18.82M	-24.77M
Capital Expenditures	-119K	-1.77M	-2.89M	n/a	-388K	-83K	-450K	-644K
Cash Acquisitions	n/a	171K	n/a	n/a	-4.27M	n/a	n/a	n/a
Purchase of Investments	-51.99M	-171K	n/a	-8.93M	-2.73M	-24.89M	-24.89M	-2.43M
Sales Maturities Of Investments	23.5M	107.38M	1.47M	8.19M	6.99M	20M	3.92M	4.47M
Other Investing Acitivies	9K	171K	1.47M	-738K	4.27M	24.89M	-20.97M	2.04M
Investing Cash Flow	-28.61M	105.77M	-1.42M	-738K	3.88M	19.92M	-21.42M	1.4M
Debt Repayment	n/a	58.51M	40.26M	n/a	n/a	n/a	-5.05M	-2.13M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	804K	1.75M	1.05M	1.02M	97K	42.12M	52.64M	-43K
Financial Cash Flow	26.63M	124.74M	41.31M	109.22M	67.97M	42.12M	47.59M	-2.17M
Net Cash Flow	-119.98M	117.62M	-15.58M	47.57M	23.22M	34.2M	7.35M	-25.54M
Free Cash Flow	-118.12M	-114.66M	-58.37M	-60.91M	-49.02M	-27.93M	-19.27M	-25.41M